← Back
$MAZE All transactions

Maze Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

7,500

Price

$0

Filed

Apr 1

Insider

Name

Dandekar Atul

Title

CSBO

CIK

0002050167

Roles

Officer

Transaction Details

Transaction Date

2026-03-30

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

51,643

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.86 to $29.84 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.87 to $30.24 per share, inclusive. | The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025.

Filing Info

Accession No.

0002050167-26-000006

Form Type

4

Issuer CIK

0001842295

Dandekar Atul's History

Date Ticker Type Value
2026-03-30 MAZE M $78K
2026-03-30 MAZE $196K
2026-03-30 MAZE $24K
2026-03-30 MAZE M $0
2025-12-30 MAZE M $1K
2025-12-30 MAZE $4K
2025-12-30 MAZE M $0
2025-12-29 MAZE M $754K
2025-12-29 MAZE $2.7M
2025-12-29 MAZE $248K

Other Insiders at MAZE (90d)

Insider Bought Sold Last
Kumar Neil 2026-03-27
Dandekar Atul
CSBO
$220K 2026-03-30
Bernstein Harold
President, R&D & CMO
$442K 2026-04-01
Bachrodt Amy
SVP, Finance
$301K 2026-04-01